The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Fostimon PFS 150 IU Powder and Solvent for Solution for Injection



IBSA Farmaceutici Italia S.r.lPA1104/002/004

Main Information

Trade NameFostimon PFS 150 IU Powder and Solvent for Solution for Injection
Active SubstancesUrofollitropin
Dosage FormPowder and solvent for solution for injection
Licence HolderIBSA Farmaceutici Italia S.r.l
Licence NumberPA1104/002/004

Group Information

ATC CodeG03GA Gonadotropins
G03GA04 urofollitropin

Status

License statusAuthorised
Licence Issued23/11/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back